Focusing on key fields such as integrated circuits, artificial intelligence, and biomedicine, what is the recent development status of Shanghai's leading industries, and what innovations and breakthroughs are there?

On April 25, the second meeting of the Standing Committee of the 16th Shanghai Municipal People's Congress was held to hear and discuss the report on the development of Shanghai's three leading industries. The paper (www.thepaper.cn) reporter learned from the Shanghai National People's Congress that Shanghai is currently focusing on building innovation heights of the three leading industries. The total scale of the three leading industries will exceed 1.4 trillion yuan in 2022, an increase of more than 10%. During the "14th Five-Year Plan" period, the scale of the three industries will be increased and talents will be doubled.

Biomedicine: The industrial scale will exceed 800 billion yuan in 2022

The scale of Shanghai's biomedical industry continues to develop, and the scale of the industry will exceed 800 billion yuan in 2022, of which the output value of the manufacturing industry will increase from 95.8 billion yuan in 2016 to 185 billion yuan, with an average annual growth of more than 10%. Project investment is robust, with total investment in the manufacturing sector jumping from 6.99 billion yuan in 2019 to 15.5 billion yuan in 2021. In 2022, the Global Investment Promotion Conference signed a total investment of 36.5 billion yuan in biomedical key projects, and 32 new major projects were started throughout the year, with an investment amount of nearly 8 billion yuan.

The factors of industrial ecological innovation are highly accessible. Shanghai's biomedical industry is rich in talents, academicians and other high-level talents account for 1/5 of the country, and the direct employment is as high as 278,000 people, of which more than 50% are under the age of 35, and the trend of youth is obvious. It has 17 domestic well-known universities and institutes and more than 30 national professional research institutions, and has successively laid out and built 35 public service platforms in the field of biomedicine. The construction of a number of innovation carriers such as the Shanghai Brain Science and brain-like Research Center was accelerated, and a number of major municipal science and technology projects such as the "Human Phenome" were promoted smoothly.

From the perspective of industrial entities, international leading enterprises are highly clustered in Shanghai, including Pfizer, Roche, Novartis, Johnson & Johnson and other international TOP20 pharmaceutical companies, 18 of which have their China or R & D production headquarters in Shanghai; Among the international TOP20 medical device companies, including Medtronic, Philips, GE, and Siemens, 17 have their R&D and production headquarters in China in Shanghai. From 2019 to 2022, the number of enterprises above designated size in the biomedical industry increased from 388 to more than 500. Fosun Pharmaceutical and Shanghai Pharmaceutical ranked Top10 in the list of China's Top 100 pharmaceutical Industry Enterprises in 2022. At the same time, 30 biomedical companies listed on the science and Technology board, accounting for about 1/4 of the country, and created a number of "first", such as the market value of United Film Medical exceeded 150 billion on the first day of listing, becoming the largest IPO on the science and Technology board in 2022.

From the perspective of industrial achievements, the coverage of innovative pharmaceutical devices is complete. The biomedical industry has the characteristics of high risk, high investment, high return and long cycle. Shanghai has made breakthroughs in the research and development of innovative pharmaceutical devices. By the end of 2019-2022, Shanghai has obtained a total of 16 category 1 innovative drugs, a total of 23 categories of innovative medical devices have been registered for the first time, and a number of the world's first new drugs (Fuquinitinib, Doglietine tablets), international first-class medical devices (PET-CT, Fireeagle stent) have emerged. Two new cell therapy drugs were approved for the first time in China (Fosun Kat Akilencel injection, Pharming Giant Noriki Orencel injection), and United Image Medical 5.0T magnetic resonance imaging system and Eptron proton therapy system achieved "the first in China". Promote the approval of the new coronavirus treatment drug VV116, effectively protect the life and health of the people.

The layout of industrial space is increasingly rational and distinctive. Shanghai strengthens the "Zhangjiang R & D + Shanghai manufacturing" orientation, improves the "1+5+X" industrial pattern, and the output value accounts for 90% of the city (1: Zhangjiang biomedical innovation leading core area, 5: Lingang New Area Precision Medicine Demonstration Zone, Oriental Meigu Life and Health Integration Development Zone, Hangzhou Bay North Bank modern pharmaceutical green bearing Zone, North Shanghai biomedical high-end Manufacturing Cluster, Minhang biomedical innovation bearing Zone, X characteristic parks), a total of 7 municipal biomedical characteristic industrial parks have been launched.

Institutional guarantee enables more development opportunities for the industry. In 2021, the Standing Committee of the Shanghai Municipal People's Congress deliberated and adopted the "Regulations on Shanghai Pudong New Area to Promote the Construction of Zhangjiang Biomedical Industry Innovation Highland", which has promoted the implementation of a number of provisions, such as the establishment of the Pudong New Area Industrial development Expert Committee, supporting the multi-point entrusted production of enterprise vaccine projects, and carrying out joint entry-exit supervision of special goods.

Artificial intelligence: The industrial scale will exceed 380 billion yuan in 2022

Since 2017, Shanghai has taken the lead in the development of artificial intelligence industry in the country, and held the first World Artificial Intelligence Conference in 2018, focusing on building the "Shanghai Highland" of artificial intelligence innovation, application demonstration, system supply, and talent gathering. The industrial scale has exceeded 380 billion yuan from 134 billion yuan in 2018 to over 380 billion yuan in 2022, with an average annual growth rate of over 29%.

First of all, the leading achievements of the artificial intelligence industry have emerged. First, the core algorithm iteration innovation, Shanghai Artificial Intelligence Laboratory released the "OpenXLab Puyuan" system and "Shusheng 2.0" large model, general vision ability and open source effect further improved. Second, the autonomous intelligent chip has crossed the mass production threshold, and there are 24 chip flow chips in mass production; Sensetime's "New Generation of artificial intelligence Computing and enabling Platform" was put into trial operation; Shanghai artificial intelligence public computing service platform was unveiled. The third is the multi-point breakthrough of intelligent terminal, reaching the humanoid intelligent robot Cloud Ginger2.0 to achieve high-precision hand-eye collaborative grasping and tool operation; Nishii unmanned commercial vehicle Q-Truck landed in overseas areas.

Secondly, the layout of major projects, the whole industrial chain continues to improve the energy level. Shanghai will settle the leading enterprises in the industrial chain and the basic platform as the key point to expand the artificial intelligence industrial cluster and cultivate the industrial momentum. Focus on the introduction of major projects, promote the cloud from the technology "global innovation headquarters" landing, its autonomous controllable man-machine collaborative operating system settled in Shanghai; Signed 25 major projects such as Jingtai Shanghai headquarters and Zero beam Galaxy Integrated intelligent driving computing platform, with a total investment of nearly 15 billion yuan; A total of 166 projects have been signed in Shanghai since 2022, with a total investment of 90.5 billion yuan. Precision layout of innovation platform. Focusing on cutting-edge hotspots such as science and intelligence, we will promote the construction of the "International Computer Law Innovation Base" led by Academician E Weinan and the "NeXus Artificial Intelligence Innovation Incubation Center" led by Professor Qi Yuan, unveil the intelligent robot manufacturing innovation center, and accelerate core technology research and innovative enterprise cultivation.

Third, since 2018, Shanghai has successfully held the "World Artificial Intelligence Conference" for five consecutive years, creating a "science and technology vane, application showcase, industrial accelerator, and governance hall" of the international artificial intelligence industry, holding more than 400 forums and activities, more than 600,000 visitors to the offline exhibition, and a total of 1.5 billion online participants, becoming an international brand event in the artificial intelligence industry.

Fourth, explore artificial intelligence policy innovation. In recent years, Shanghai has successively introduced the country's first artificial intelligence algorithm innovation plan, local standard system and the "14th Five-Year Plan". In 2022, the Standing Committee of the Shanghai Municipal People's Congress deliberated and passed the Regulations of Shanghai Municipality on Promoting the Development of Artificial Intelligence Industry, which is China's first provincial-level local regulation on artificial intelligence.

Fifth, the industrial support system is improving. First, the development pattern of industrial agglomeration is more prominent, attracting more than 1,000 advantageous enterprises in the artificial intelligence industry chain, covering the base layer, technology layer, product layer, and application layer of the full stack industry chain, and the "4+X" and "human" industrial layout (Zhangjiang, West Bund, Maqiao, Lingang, etc.) is further deepened. The second is the connection of major application scenarios, and 18 scenarios such as the "East China Sea Bridge automatic driving scenario" were selected into the Ministry of Industry and Information Technology's 100 typical artificial intelligence application scenarios, the total number of which is first in the country. Third, financial investment was further activated, the Shanghai Artificial Intelligence Industry Investment Fund leveraged 100 billion social capital, and started the new track sub-fund to raise funds; Bank of China, Shanghai Pudong Development and other banking syndicates set up 10 billion credit innovation support tools; Industrial and Commercial Bank of China and five other banks issued 65 billion yuan of credit lines to help enterprises rescue.

Surging news senior reporter Li Jiawei